RE:RE:RE:RE:This not a cancer cure , how much time WOW! A roughly 10% difference in order sizes of this magnitude to prove your point. You have no idea why there's this "slight" difference.
* cost
* scalability to meet demand
* tendering process
* etc, etc, etc
If Celltrion were so much better why not give them the whole order ....in the end it would be the responsible thing to do, right?
https://financialpost.com/pmn/press-releases-pmn/business-wire-news-releases-pmn/celltrion-awarded-up-to-626-million-from-the-department-of-defense-to-supply-covid-19-point-of-care-poc-rapid-antigen-test-kits
"The test kits to be supplied through this contact are point-of-care tests (POCT) which can only be used in the presence of medical professionals."
"...resulting in improved sensitivity of 93.3% and specificity of 99.0%." The same as Abbott Labs!!!
AcuVid could occupy this niche but the ultimate goal as stated by Rob Fia is that it would be a widely used at home test because of the cost and the ease of acquiring a sample. Quite frankly the only thing working against Therma Bright is that it is not one of the heavy hitters in the world of pharmaceuticals....imho precisely one of the reasons they have the relationship with Ridge Global.
Cheers!!!
hemi3tc wrote: That is why the US government gave a bigger order to Celltrion.
Sep 21, 2021
The U.S. government has agreed to purchase point-of care COVID-19 tests from Abbott Laboratories and Celltrion Inc to ship to nursing homes and other high risk populations as part of its broader plan to purchase $2 billion in rapid coronavirus tests, a person familiar with the matter said on Tuesday.
The federal government will purchase tests as needed and has agreed to spend up to $626 million in its agreement with Celltrion and $554.4 million in its deal with Abbott, the person said.
Smokey1958 wrote: What are you talking about? With all due respect have you actually read anything on rapid antigen tests. They are, by their nature not as accurate as the gold standard PCR tests. They are well understood to be most accurate and useful when catching individuals at their most transmissible.
None of the tests that have met FDA EUA criterion, received their CE mark (which AcuVid has by the way), met with HC approval or been authorized by other jurisdictions is as good as a PCR test. In fact the most dominant test in this group thus far, BinaxNOW by Abbott Labs has the same limitations and the same Sensitivity and Specificity as AcuVid.